Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
Christian Bär, Shambhabi Chatterjee, Inês Falcão‐Pires, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 11, pp. 1805-1819
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity
Dongchao Lu, Shambhabi Chatterjee, Ke Xiao, et al.
European Heart Journal (2022) Vol. 43, Iss. 42, pp. 4496-4511
Open Access | Times Cited: 72
miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
Alessandro Matarese, Jessica Gambardella, Celestino Sardu, et al.
Biomedicines (2020) Vol. 8, Iss. 11, pp. 462-462
Open Access | Times Cited: 128
miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells
Pasquale Mone, Jessica Gambardella, Xujun Wang, et al.
Non-Coding RNA (2021) Vol. 7, Iss. 1, pp. 9-9
Open Access | Times Cited: 56
Non-Coding RNAs: Prevention, Diagnosis, and Treatment in Myocardial Ischemia–Reperfusion Injury
Mihnea-Cosmin Marinescu, Andrada-Luciana Lazăr, Monica Mihaela Marta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2728-2728
Open Access | Times Cited: 51
The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases
Denise Busscher, Reinier A. Boon, Rio P. Juni
Clinical Science (2022) Vol. 136, Iss. 15, pp. 1157-1178
Open Access | Times Cited: 43
Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development
Timothy A. McKinsey, Roger Foo, Chukwuemeka George Anene-Nzelu, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3482-3498
Open Access | Times Cited: 40
Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart
Sean M. Davidson, Teresa Padró, Sveva Bollini, et al.
Cardiovascular Research (2021) Vol. 117, Iss. 10, pp. 2161-2174
Open Access | Times Cited: 41
Insights into research on myocardial ischemia/reperfusion injury from 2012 to 2021: a bibliometric analysis
Ming Bai, Jingjing Zhang, De Chen, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 17
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 17
The vasculature: a therapeutic target in heart failure?
Guillermo Luxán, Stefanie Dimmeler
Cardiovascular Research (2021) Vol. 118, Iss. 1, pp. 53-64
Open Access | Times Cited: 38
Small Extracellular Vesicles Derived from Induced Pluripotent Stem Cells in the Treatment of Myocardial Injury
Wan-ting Meng, Hai-dong Guo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4577-4577
Open Access | Times Cited: 12
MicroRNA-143-3p and miR-452-5p: A Fingerprint for the Diagnosis of Aortic Stenosis in the Geriatric Population
Mónica Ramos, Francisco J. Enguita, Fernando Bonet, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 671-671
Open Access
A Novel Protein NAB1‐356 Encoded by circRNA circNAB1 Mitigates Atrial Fibrillation by Reducing Inflammation and Fibrosis
William W. Du, Muhammad Rafiq, Hui Yuan, et al.
Advanced Science (2025)
Open Access
Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress
Jean C. Bikomeye, Janée D. Terwoord, Janine H. Santos, et al.
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 4, pp. H702-H720
Open Access | Times Cited: 18
miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
Urna Kansakar, Jessica Gambardella, Fahimeh Varzideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10242-10242
Open Access | Times Cited: 18
Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity
Esko Kankuri, Piet Finckenberg, J. Leinonen, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 4, pp. 806-817
Open Access | Times Cited: 10
Non-Coding RNAs in Cell-to-Cell Communication: Exploiting Physiological Mechanisms as Therapeutic Targets in Cardiovascular Pathologies
Javier Laura Francés, Elettra Musolino, Roberto Papait, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2205-2205
Open Access | Times Cited: 8
MIAT, a potent CVD-promoting lncRNA
Chao Yang, Yong Zhang, Baofeng Yang
Cellular and Molecular Life Sciences (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 20
Identification of a novel small-molecule inhibitor of miR-29b attenuates muscle atrophy
Qi Liu, Weilin Yuan, Yuwei Yan, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 527-540
Open Access | Times Cited: 7
Circular RNAs in Cardiac Regeneration: Cardiac Cell Proliferation, Differentiation, Survival, and Reprogramming
Julia Mester-Tonczar, Ena Hašimbegović, Andreas Spannbauer, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 17
miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations
Pasquale Mone, Jessica Gambardella, Xujun Wang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 15
LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial
Jennifer Meessen, Christian Bär, Filippo Maria di Dona, et al.
Clinical Chemistry (2021) Vol. 67, Iss. 12, pp. 1721-1731
Open Access | Times Cited: 15
Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6
Circular RNAs at the intersection of cancer and heart disease: potential therapeutic targets in cardio-oncology
Dimyana Neufeldt, Sarah Cushman, Christian Bär, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 7, pp. 1495-1508
Closed Access | Times Cited: 6
Biologics and cardiac disease: challenges and opportunities
Giulio Ciucci, Andrea Colliva, Roman Vuerich, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 894-905
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top